2000年3月9日,在深圳证券交易所成功上市的三九医药风光无限。时隔五年,昔日的光环早已散去,却以资产重组的结果而悲情收场。这其中既有其自身连锁经营的不足,也有其大股东三九集团引致的盘根错节的财务问题。其中的前因后果,昔往今来都值得我们认真地思索,思索一个我们也可能重蹈覆 March 9, 2000, the successful listing of the Shenzhen Stock Exchange March 9 Pharmaceutical scene. After a lapse of five years, the aura of the past has long been dispersed, but the result of asset restructuring and sad end. This has both its own lack of chain operations, but also has its shareholding of 39 groups caused by the root of the financial problems. The antecedents and the consensuses, the past and present are all worth our careful thinking, thinking one we may also repeat